These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 18030348)
1. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. Thedieck K; Polak P; Kim ML; Molle KD; Cohen A; Jenö P; Arrieumerlou C; Hall MN PLoS One; 2007 Nov; 2(11):e1217. PubMed ID: 18030348 [TBL] [Abstract][Full Text] [Related]
2. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906 [TBL] [Abstract][Full Text] [Related]
3. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells. Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235 [TBL] [Abstract][Full Text] [Related]
4. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. Oshiro N; Takahashi R; Yoshino K; Tanimura K; Nakashima A; Eguchi S; Miyamoto T; Hara K; Takehana K; Avruch J; Kikkawa U; Yonezawa K J Biol Chem; 2007 Jul; 282(28):20329-39. PubMed ID: 17517883 [TBL] [Abstract][Full Text] [Related]
5. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. Wang L; Harris TE; Roth RA; Lawrence JC J Biol Chem; 2007 Jul; 282(27):20036-44. PubMed ID: 17510057 [TBL] [Abstract][Full Text] [Related]
6. Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction. Hong-Brown LQ; Brown CR; Kazi AA; Huber DS; Pruznak AM; Lang CH J Cell Biochem; 2010 Apr; 109(6):1172-84. PubMed ID: 20127721 [TBL] [Abstract][Full Text] [Related]
7. PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. Fonseca BD; Smith EM; Lee VH; MacKintosh C; Proud CG J Biol Chem; 2007 Aug; 282(34):24514-24. PubMed ID: 17604271 [TBL] [Abstract][Full Text] [Related]
8. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells. Misra UK; Pizzo SV PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152 [TBL] [Abstract][Full Text] [Related]
9. The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling. Rapley J; Oshiro N; Ortiz-Vega S; Avruch J J Biol Chem; 2011 Nov; 286(44):38043-38053. PubMed ID: 21914810 [TBL] [Abstract][Full Text] [Related]
10. Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. Wang L; Harris TE; Lawrence JC J Biol Chem; 2008 Jun; 283(23):15619-27. PubMed ID: 18372248 [TBL] [Abstract][Full Text] [Related]
12. Alkaline intracellular pH (pHi) increases PI3K activity to promote mTORC1 and mTORC2 signaling and function during growth factor limitation. Kazyken D; Lentz SI; Wadley M; Fingar DC J Biol Chem; 2023 Sep; 299(9):105097. PubMed ID: 37507012 [TBL] [Abstract][Full Text] [Related]
13. MITF-MIR211 axis is a novel autophagy amplifier system during cellular stress. Ozturk DG; Kocak M; Akcay A; Kinoglu K; Kara E; Buyuk Y; Kazan H; Gozuacik D Autophagy; 2019 Mar; 15(3):375-390. PubMed ID: 30290719 [TBL] [Abstract][Full Text] [Related]
14. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Sancak Y; Thoreen CC; Peterson TR; Lindquist RA; Kang SA; Spooner E; Carr SA; Sabatini DM Mol Cell; 2007 Mar; 25(6):903-15. PubMed ID: 17386266 [TBL] [Abstract][Full Text] [Related]
15. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421 [TBL] [Abstract][Full Text] [Related]
16. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Vander Haar E; Lee SI; Bandhakavi S; Griffin TJ; Kim DH Nat Cell Biol; 2007 Mar; 9(3):316-23. PubMed ID: 17277771 [TBL] [Abstract][Full Text] [Related]
17. Role of PRAS40 in Akt and mTOR signaling in health and disease. Wiza C; Nascimento EB; Ouwens DM Am J Physiol Endocrinol Metab; 2012 Jun; 302(12):E1453-60. PubMed ID: 22354785 [TBL] [Abstract][Full Text] [Related]
18. Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. Sato T; Nakashima A; Guo L; Tamanoi F J Biol Chem; 2009 May; 284(19):12783-91. PubMed ID: 19299511 [TBL] [Abstract][Full Text] [Related]
19. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage. Völkers M; Konstandin MH; Doroudgar S; Toko H; Quijada P; Din S; Joyo A; Ornelas L; Samse K; Thuerauf DJ; Gude N; Glembotski CC; Sussman MA Circulation; 2013 Nov; 128(19):2132-44. PubMed ID: 24008870 [TBL] [Abstract][Full Text] [Related]
20. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis. Mi W; Ye Q; Liu S; She QB Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]